Scottish Health Innovations Ltd

Ambicare Health

Ambicare Health is a spin-out company from NHS Scotland via Scottish Health Innovations Ltd (SHIL), St Andrew's University.

Ambicare's light-emitting source, which will revolutionise the treatment of skin cancer, was created at Ninewells Hospital, Dundee and has been further developed into products for the treatment of acne and for wrinkle reduction. These new developments open up wider markets for the company and further enhance future success of Ambicare.Ambicare Health Ltd (previously known as Lumicure Ltd) has developed a portfolio of wearable light sources for medical and consumer healthcare applications.
The company's products build upon patented technologies in ambulatory lighting for skin treatment and are sold under the brand name Ambulight. The company's first medical product, Ambulight PDT, is a light-emitting sticking plaster for the treatment of non melanoma skin cancer (NMSC).
This CE marked medical device launched in Europe in October 2009. Ambulight PDT is a simple and easily applied, light emitting plaster, used in photodynamic therapy treatment (PDT). PDT is as a well established alternative to surgery for many forms of skin cancer.
In addition to medical devices, Ambicare are developing consumer healthcare phototherapy products. Applications include acne (Ambulight: Acne) and skin rejuvenation (Ambulight: Rejuvenate). Both of these products will launch in 2010.




For further information about Ambicare please contact:

Ian Muirhead (CEO)Lumicure

Mobile Telephone: +44 (0)771 498 0617

or Sandy Allan at Scottish Health Innovations Ltd.
 

Stay Informed

If you would like to keep up to date with what is happening in SHIL then sign up for our newsletter here.